Retrospective Study
Copyright ©The Author(s) 2016.
World J Hepatol. Mar 18, 2016; 8(8): 411-420
Published online Mar 18, 2016. doi: 10.4254/wjh.v8.i8.411
Table 1 Surgical procedures
Case No.DiagnosisNo. of tumorSize of the largest tumor, cmTHVE and modificationsTHVE duration, minHepatectomyVascular reconstruction proceduresOutcome
1HCC120.0Standard with switching15Extended right hepatectomyDirect suture of IVCAlive without disease, 60 mo postoperative
2Liver metastasis120.0Standard with switching19Extended right hepatectomyIMV patch for HV, Direct suture of IVCAlive with disease, 17 mo postoperative
3Liver metastasis29.0Standard with switching123Extended right hepatectomyIMV patch for HV and IVCAlive with disease, 10 mo postoperative
4Liver metastasis16.0Oblique2 (right)26Right hepatectomyIMV patch graft for IVCDied of disease, 27 mo postoperative
5Liver metastasis42.5Oblique2 (right)20Partial resectionIMV patch graft for IVC and HVAlive without disease, 15 mo postoperative
6Liver metastasis1018.0Oblique2 (right)7Right hepatectomy, partial resectionDirect suture of IVCDied of disease, 8 mo postoperative
7Liver metastasis155.5Oblique2 (right)7Extended anterior sectionectomy, partial resectionDirect suture of IVCDied of disease, 9 mo postoperative
8Liver metastasis95.5Oblique2 (left)10Segmentectomy, partial resectionDirect suture of IVC and HVsAlive without disease, 13 mo postoperative
Table 2 Operative parameters and postoperative course of 8 patients
ParametersValues or number of patients
Operation time482 ± 108 min
Blood loss1778 ± 1233 mL
THVE duration13.4 ± 8.4 min
Postoperative liver function
TB (mg/dL)
Maximum2.01 (0.98-4.4)
POD71.08 (0.75-1.86)
AST (IU/L)
Maximum513 (238-1058)
POD730 (20-41)
ALT (IU/L)
Maximum319 (179-824)
POD764 (36-115)
PT (%)
Minimum64.4 (55.3-88.8)
POD788.1 (61.6-107.8)
Complications
Clavien-Dindo classification
I2
II1
≥ III0
Operative mortality0
Hospital stay (d)15 (12-24)